EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?

Christina Clavelo-Farrow, Patricia Thomas iD

Diabetic Medicine · 2023

DOI: 10.1111/dme.15198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetic Medicine, 2023. Verfasst von Christina Clavelo-Farrow und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) in humans is typically preceded by elevated levels of circulatory long‐chain free fatty acids (LC‐FFA). These excess LC‐FFA are widely thought to be taken up by pancreatic β‐cells, contributing to their dysfunction and death during the development of T2D; a process that has been termed lipotoxicity. Depending on their degree of saturation and carbon chain length, LC‐FFA can exert different effects on pancreatic β‐cells viability and function in vitro. Long‐chain saturated fatty acids (LC‐SFA) are thought to be toxic, whereas monounsaturated fatty acids are not and may even offer protection against the toxic effects of LC‐SFAs. However, the mechanism of LC‐FFA uptake into pancreatic β‐cells is poorly understood, partly because it has been an understudied area of research. Determining how LC‐FFA are taken up into β‐cells is crucial for later formulation of therapies to prevent potential cellular overload of LC‐FFA, thereby slowing the onset of T2D. In this work, we detail more than 40 years of literature investigating the role of membrane‐associated transport proteins in LC‐FFA uptake. By focussing on what is known in other cell types, we highlight where we can extrapolate our current understanding of protein‐mediated transport to β‐cells and uncover where further understanding is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Secreting CellsHumansCarrier ProteinsFatty AcidsFatty Acids, Nonesterified

Stichwörter der Autor:innen

candidate transport proteinsfatty acid uptakelipotoxicitylong-chain fatty acidsβ-cells

Substanzen

Carrier ProteinsFatty AcidsFatty Acids, Nonesterified

Autor:innen und Institutionen

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

ORCID-Profile: Patricia Thomas

Förderung

  • Medical Research Council

Zitieren

APA

Clavelo-Farrow, C., & Thomas, P. (2023). The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?. Diabetic Medicine. https://doi.org/10.1111/dme.15198

Vancouver

Clavelo-Farrow C, Thomas P. The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?. Diabetic Medicine. 2023. doi:10.1111/dme.15198

BibTeX
@article{ClaveloFarrow2023,
  author = {Clavelo-Farrow, Christina and Thomas, Patricia},
  title = {The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?},
  journal = {Diabetic Medicine},
  year = {2023},
  doi = {10.1111/dme.15198}
}
Kostenlos starten →